Why the study?
Does ropivacaine compared to bupivacaine improve pulmonary function changes in patients with chronic renal failure undergoing interscalene brachial plexus block?
Population
42 patients with chronic renal failure undergoing interscalene brachial plexus anesthesia for creation of…
Comparison
30 mL of 0.33% ropivacaine for interscalene… vs 30 mL of 0.33% bupivacaine for interscalene…
Design
RCT, randomly allocated, double-blind
Authors
Loading...
Favors ropivacaine over bupivacaine to limit pulmonary impairment in chronic renal failure interscalene blocks; extends agent comparisons to this population.
Does ropivacaine compared to bupivacaine improve pulmonary function changes in patients with chronic renal failure undergoing interscalene brachial plexus block?
In patients with chronic renal failure undergoing interscalene brachial plexus block, 0.33% ropivacaine results in less impairment of pulmonary function compared to 0.33% bupivacaine.
Altıntaş et al. (2005) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: